<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- The HAS recommends generalizing screening for sickle cell disease to all newborns Nov 15, 2022
- Doctor Who leaked filming footage, first look at David Tennant and Catherine Tate May 24, 2022
- Called quick ways to lower blood sugar levels Aug 15, 2020
- Named the perfect food for late dinner Jul 15, 2020
- Cry of Independence in Tlaxcala 2021: How it will be Sep 4, 2021
- Seven foods that can worsen the mood Aug 8, 2020
- Covid-19: hydroxychloroquine walking, irrefutable proof Jul 13, 2020